International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.
Isaji S, Mizuno S, Windsor JA, Bassi C, Fernández-Del Castillo C, Hackert T, Hayasaki A, Katz MHG, Kim SW, Kishiwada M, Kitagawa H, Michalski CW, Wolfgang CL.
Pancreatology. 2018 Jan;18(1):2-11. doi: 10.1016/j.pan.2017.11.011. Epub 2017 Nov 22.
Radiotherapy in the management of rare gastrointestinal cancers: A systematic review.
Bellefkih FZ, Benchakroun N, Lalya I, Amaoui B, El Kacemi H, Acharki A, El Hfid M, El Mazghi A, Chekrine T, Bouchbika Z, Jouhadi H, Sahraoui S, Tawfiq N, Michalet M.
Cancer Radiother. 2023 Sep;27(6-7):622-637. doi: 10.1016/j.canrad.2023.06.010. Epub 2023 Jul 25.
Parenchymal Sparing Resection: Options in Duodenal and Pancreatic Surgery.
Marchese U, Tzedakis S, Abou Ali E, Turrini O, Delpero JR, Coriat R, Fuks D.
J Clin Med. 2021 Apr 2;10(7):1479. doi: 10.3390/jcm10071479.
Inflammatory myofibroblastic duodenal tumor: A rare cause of massive intestinal bleeding.
González MG, Vela D, Álvarez M, Caramés J.
Cancer Biomark. 2016 Mar 11;16(4):555-7. doi: 10.3233/CBM-160597.
GASTROINTESTINAL STROMAL TUMOURS.
Chand K, Chatterjee T.
Med J Armed Forces India. 2000 Jan;56(1):40-44. doi: 10.1016/S0377-1237(17)30089-8. Epub 2017 Jun 8.
Clinical impact of endoscopic papillectomy for benign-malignant borderline lesions of the major duodenal papilla.
Harano M, Ryozawa S, Iwano H, Taba K, Sen-Yo M, Sakaida I.
J Hepatobiliary Pancreat Sci. 2011 Mar;18(2):190-4. doi: 10.1007/s00534-010-0327-8.
Dramatic disappearance of hyperglycemia and abnormal neurologic symptoms after resection of duodenal gastrointestinal stromal tumor.
Wannasri T, Luvira V, Pairojkul C.
Clin J Gastroenterol. 2022 Dec;15(6):1067-1071. doi: 10.1007/s12328-022-01683-9. Epub 2022 Jul 30.
Multimodal Management of Grade 1 and 2 Pancreatic Neuroendocrine Tumors.
Marchese U, Gaillard M, Pellat A, Tzedakis S, Abou Ali E, Dohan A, Barat M, Soyer P, Fuks D, Coriat R.
Cancers (Basel). 2022 Jan 15;14(2):433. doi: 10.3390/cancers14020433.
Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial.
Taniguchi CM, Frakes JM, Aguilera TA, Palta M, Czito B, Bhutani MS, Colbert LE, Abi Jaoude J, Bernard V, Pant S, Tzeng CD, Kim DW, Malafa M, Costello J, Mathew G, Rebueno N, Koay EJ, Das P, Ludmir EB, Katz MHG, Wolff RA, Beddar S, Sawakuchi GO, Moningi S, Slack Tidwell RS, Yuan Y, Thall PF, Beardsley RA, Holmlund J, Herman JM, Hoffe SE.
Lancet Oncol. 2023 Dec;24(12):1387-1398. doi: 10.1016/S1470-2045(23)00478-3.
Total Pancreatectomy with Autologous Islet Cell Transplantation-The Current Indications.
Jabłońska B, Mrowiec S.
J Clin Med. 2021 Jun 20;10(12):2723. doi: 10.3390/jcm10122723.
